Potential drug molecule shows enhanced anti-HIV activity
Thursday, August 9, 2012 - 15:00
in Health & Medicine
Researchers have shown that minimal modification of a synthetic peptide with anti-HIV activity results in a new compound with more than two orders of magnitude higher binding affinity to the chemokine receptor CXCR4 and greatly improved anti-HIV activity. This could be a step toward the design of new, more effective drugs against AIDS, inflammatory diseases, and some forms of cancer.